Web17 feb. 2024 · January 30, 2024. REDWOOD CITY, Calif. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology … WebEXPANDED ACCESS. Jasper is a clinical stage biotechnology company focused on the development of novel curative therapies by focusing on the biology of the hematopoietic stem cell. Jasper’s lead program, Briquilimab, is an investigational therapy currently being studied in multiple clinical trials for serious and life-threatening conditions.
JSPR Jasper Therapeutics Inc. Profile MarketWatch
Web27 feb. 2024 · In the last 3 months, 7 analysts have offered 12-month price targets for Jasper Therapeutics. The company has an average price target of $5.77 with a high of … Web31 mar. 2024 · Jasper Therapeutics is a biotechnology company focused on the development of novel curative therapies based on the biology of the hematopoietic stem cell. The company is advancing two potentially groundbreaking programs. JSP191, an anti-CD117 monoclonal antibody, is in clinical development as a conditioning agent that … campgrounds near fort campbell
$4M Bet On Jasper Therapeutics? Check Out These 3 Penny Stocks …
WebAcum 2 zile · The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Gary Rieschel acquired a total 2,666,666 shares an average price of $1.50. To acquire these shares, it cost around $4 million. Web21 iun. 2024 · REDWOOD CITY, Calif. and NEW YORK and BASEL, Switzerland, June 21, 2024 /PRNewswire/ -- Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and ... campgrounds near folsom ca